Circulating CD34-positive cells provide a marker of vascular risk associated with cognitive impairment

26Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Maintenance of uninterrupted cerebral circulation is critical for neural homeostasis. The level of circulating CD34-positive (CD34+) cells has been suggested as an index of cerebrovascular health, although its relationship with cognitive function has not yet been defined. In a group of individuals with cognitive impairment, the level of circulating CD34+ cells was quantified and correlated with clinical diagnoses. Compared with normal subjects, a significant decrease in circulating CD34+ cells was observed in patients with vascular-type cognitive impairment, although no significant change was observed in patients with Alzheimer's-type cognitive impairment who had no evidence of cerebral ischemia. The level of cognitive impairment was inversely correlated with numbers of circulating CD34+ cells in patients with vascular-type cognitive impairment, but not Alzheimer's type. We propose that the level of circulating CD34+ cells provides a marker of vascular risk associated with cognitive impairment, and that differences in the pathobiology of Alzheimer's- and vascular-type cognitive impairment may be mirrored in levels of circulating CD34+ cells in these patient populations. © 2008 ISCBFM All rights reserved.

Cite

CITATION STYLE

APA

Taguchi, A., Matsuyama, T., Nakagomi, T., Shimizu, Y., Fukunaga, R., Tatsumi, Y., … Naritomi, H. (2008). Circulating CD34-positive cells provide a marker of vascular risk associated with cognitive impairment. Journal of Cerebral Blood Flow and Metabolism, 28(3), 445–449. https://doi.org/10.1038/sj.jcbfm.9600541

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free